Frazier Lifesciences Acquisition Corporation /
NewAmsterdam Pharma
Frazier Lifesciences Acquisition Corporation completes NewAmsterdam Pharma combination
- Terms
- Not stated
- Stage
- Closed
What happened
Frazier Lifesciences Acquisition Corporation completed its business combination with NewAmsterdam Pharma Holding B.V. on Nov. 23, 2022, after the merger and domestication took effect.
Following the transaction, NewAmsterdam Pharma Company N.V. began trading on The Nasdaq Stock Market under the symbol “NAMS.”
The source
Everything on this page comes from the source below.
Frazier Lifesciences Acquisition Corporation completes NewAmsterdam Pharma combination
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly